Anouk A. J. Heine

Understanding drugs in breast cancer through drug sensitivity screening

Hinrich W. H. Göhlmann, John W. M. Martens, John A. Foekens, 2015, SpringerPlus.

Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes

James D. Brenton, Muhammed Murtaza, Anna M. Piskorz, 2014, PloS one.

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

S. Sleijfer, J. Martens, J. Foekens, 2011, Breast Cancer Research and Treatment.

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer

J. Foekens, J. Klijn, A. Sieuwerts, 2013, Breast Cancer Research and Treatment.

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

John W M Martens, Agnes Jager, J. Foekens, 2019, PloS one.

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

J. Foekens, M. Riaz, Marijn T. M. van Jaarsveld, 2013, Breast Cancer Research.

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

J. Foekens, M. Riaz, Marijn T. M. van Jaarsveld, 2013, Breast Cancer Research.